Previous Close | 52.34 |
Open | 52.58 |
Bid | 0.00 x 1200 |
Ask | 0.00 x 1200 |
Day's Range | 51.53 - 52.70 |
52 Week Range | 47.58 - 71.07 |
Volume | |
Avg. Volume | 17,096,811 |
Market Cap | 104.325B |
Beta (5Y Monthly) | 0.37 |
PE Ratio (TTM) | 13.37 |
EPS (TTM) | 3.86 |
Earnings Date | Apr 25, 2024 |
Forward Dividend & Yield | 2.40 (4.65%) |
Ex-Dividend Date | Apr 04, 2024 |
1y Target Est | 50.18 |
Subscribe to Yahoo Finance Plus to view Fair Value for BMY
James D. Robinson III, who transformed American Express into a financial-services supermarket but left the company in 1993 after a high-profile clash with its directors, died Monday at the St. Francis Hospital in Roslyn, N.Y. The courtly son of a prominent banking family in Atlanta, Robinson was regularly in the headlines as he assembled and then began dismantling a financial conglomerate in the 1980s and early 1990s. Both of them were involved in the 1988 takeover battle for control of the cookie and cracker giant RJR Nabisco, which inspired the book and movie “Barbarians at the Gate.”
Bristol Myers' (BMY) Abecma gets eight out of 11 votes from the FDA's ODAC for patients with triple-class exposed relapsed or refractory multiple myeloma in earlier lines of therapy.
PRINCETON, N.J., March 18, 2024--Bristol Myers Squibb (NYSE: BMY) today announced that it has successfully completed its acquisition of Karuna Therapeutics, Inc. ("Karuna"). With the acquisition's completion, Karuna shares have ceased trading on the Nasdaq Global Select Market and Karuna is now a wholly owned subsidiary of Bristol Myers Squibb ("BMS").